CIVAX
Price
$19.75
Change
+$0.11 (+0.56%)
Updated
Aug 15 closing price
Net Assets
2.54B
RERAX
Price
$58.21
Change
+$0.34 (+0.59%)
Updated
Aug 15 closing price
Net Assets
135.22B
Interact to see
Advertisement

CIVAX vs RERAX

Header iconCIVAX vs RERAX Comparison
Open Charts CIVAX vs RERAXBanner chart's image
American Funds International Vntg 529-A
Price$19.75
Change+$0.11 (+0.56%)
VolumeN/A
Net Assets2.54B
American Funds EUPAC R1
Price$58.21
Change+$0.34 (+0.59%)
VolumeN/A
Net Assets135.22B
CIVAX vs RERAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CIVAX vs. RERAX commentary
Aug 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CIVAX is a StrongBuy and RERAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RERAX has more cash in the bank: 135B vs. CIVAX (2.54B). CIVAX pays higher dividends than RERAX: CIVAX (1.10) vs RERAX (0.24). CIVAX was incepted earlier than RERAX: CIVAX (6 years) vs RERAX (23 years). RERAX (1.57) is less costly to investors than CIVAX (0.98). RERAX is a more actively managed with annual turnover of: 35.00 vs. CIVAX (20.00). CIVAX (250) and RERAX (250) have matching initial minimum investment requirements. CIVAX annual gain was more profitable for investors over the last year : 15.26 vs. RERAX (7.03). CIVAX return over 5 years is better than : 38.14 vs. RERAX (8.34).
CIVAXRERAXCIVAX / RERAX
Total Expense Ratio0.981.5762%
Annual Report Gross Expense Ratio0.981.5762%
Fund Existence6 years23 years-
Gain YTD21.76315.427141%
Front Load4%N/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets2.54B135B2%
Annual Yield % from dividends1.100.24466%
Returns for 1 year15.267.03217%
Returns for 3 years40.9421.84187%
Returns for 5 years38.148.34457%
Returns for 10 yearsN/A25.54-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JRSIX12.74N/A
N/A
JH Adaptive Risk Mgd U.S. Eq I
ITRAX24.47N/A
N/A
VY® T. Rowe Price Capital Apprec A
ALSAX10.46N/A
N/A
Alger Small Cap Growth A
BMSBX14.80N/A
N/A
MFS Blended Research Mid Cap Eq B
BERCX17.68-0.12
-0.67%
Carillon Chartwell Mid Cap Value I